Celgene

This study followed 877 people with moderate to severe ulcerative colitis to see how safe and effective the oral medication RPC1063 is over the long term. Only people who had already been in previous RPC1063 trials could join this extension study. The main goal was to monitor sid…

This study tested an experimental treatment called bb2121, a type of CAR-T cell therapy, for adults with multiple myeloma that has come back after treatment or is considered high-risk. Doctors collected and modified each participant's own immune cells to target the cancer, then i…

This Phase 3 study tested an investigational drug called CC-93538 for adults and adolescents in Japan with eosinophilic gastroenteritis, a rare inflammatory gut disease. The trial aimed to see if the drug could reduce gut inflammation and improve symptoms like stomach pain, heavi…

This early-stage study tested a new drug called CC-94676 in men with advanced prostate cancer that had spread and was no longer responding to standard hormone therapies. The main goal was to find a safe dose and understand how the drug behaves in the body. Researchers also looked…

This study tested whether a daily oral medication called ozanimod could help control symptoms and induce remission in Japanese adults with moderate to severe ulcerative colitis. About 198 participants were randomly assigned to receive either the drug or a placebo pill for an init…

This early-stage study tested how a new drug called golcadomide behaves in people with moderate to severe liver problems compared to healthy volunteers. Researchers gave a single dose to 29 participants to measure drug levels in the blood and check for safety issues. The goal was…